In breast cancer models, ISG15 and/or ISGylation correlate with aggressive features such as, cell cycle progression, cell motility and tumour growth in xenograft models [28, 29, 33], yet, we still do not know if ISG15 is just a bystander or indeed a driver. Here, ISG15 is linked to breast carcinoma.